U.S. Census Bureau‐assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID‐19 pandemic

Background The disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during...

Full description

Saved in:
Bibliographic Details
Published inDepression and anxiety Vol. 37; no. 10; pp. 954 - 956
Main Authors Twenge, Jean M., Joiner, Thomas E.
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.10.2020
Subjects
Online AccessGet full text
ISSN1091-4269
1520-6394
1520-6394
DOI10.1002/da.23077

Cover

Loading…
Abstract Background The disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic. Methods Participants (n = 336,525) were from U.S. Census Bureau‐administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire‐2 screening for depressive disorder and the Generalized Anxiety Disorder‐2 screening for anxiety disorders. Results Compared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23–May 4, 2020 and the May 21–26, 2020 administrations, while the prevalence of depression increased slightly. Conclusions U.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.
AbstractList The disruptions to daily life caused by the coronavirus disease 2019 (COVID-19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic.BACKGROUNDThe disruptions to daily life caused by the coronavirus disease 2019 (COVID-19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic.Participants (n = 336,525) were from U.S. Census Bureau-administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire-2 screening for depressive disorder and the Generalized Anxiety Disorder-2 screening for anxiety disorders.METHODSParticipants (n = 336,525) were from U.S. Census Bureau-administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire-2 screening for depressive disorder and the Generalized Anxiety Disorder-2 screening for anxiety disorders.Compared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23-May 4, 2020 and the May 21-26, 2020 administrations, while the prevalence of depression increased slightly.RESULTSCompared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23-May 4, 2020 and the May 21-26, 2020 administrations, while the prevalence of depression increased slightly.U.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.CONCLUSIONSU.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.
Background The disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic. Methods Participants (n = 336,525) were from U.S. Census Bureau‐administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire‐2 screening for depressive disorder and the Generalized Anxiety Disorder‐2 screening for anxiety disorders. Results Compared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23–May 4, 2020 and the May 21–26, 2020 administrations, while the prevalence of depression increased slightly. Conclusions U.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.
BackgroundThe disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic.MethodsParticipants (n = 336,525) were from U.S. Census Bureau‐administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire‐2 screening for depressive disorder and the Generalized Anxiety Disorder‐2 screening for anxiety disorders.ResultsCompared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23–May 4, 2020 and the May 21–26, 2020 administrations, while the prevalence of depression increased slightly.ConclusionsU.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.
The disruptions to daily life caused by the coronavirus disease 2019 (COVID-19) pandemic may have impacted mental health, particularly mood disorders. This study aimed to compare prevalence rates of anxiety disorder and depressive disorder in national samples in the U.S. before and during the pandemic. Participants (n = 336,525) were from U.S. Census Bureau-administered nationally representative probability samples, one from the first half of 2019 and four during the pandemic in April and May 2020. All participants completed the Patient Health Questionnaire-2 screening for depressive disorder and the Generalized Anxiety Disorder-2 screening for anxiety disorders. Compared to U.S. adults in 2019, U.S. adults in April and May 2020 were more than three times as likely to screen positive for depressive disorders, anxiety disorders, or one or both, with more than one out of three screening positive for one or both. The prevalence of anxiety decreased slightly between the April 23-May 4, 2020 and the May 21-26, 2020 administrations, while the prevalence of depression increased slightly. U.S. adults in 2020 are considerably more likely to screen positive for mood disorders than in 2019, with anxiety declining and depression increasing from April to May.
Author Joiner, Thomas E.
Twenge, Jean M.
Author_xml – sequence: 1
  givenname: Jean M.
  orcidid: 0000-0002-6542-8281
  surname: Twenge
  fullname: Twenge, Jean M.
  email: jeantwenge@gmail.com
  organization: San Diego State University
– sequence: 2
  givenname: Thomas E.
  surname: Joiner
  fullname: Joiner, Thomas E.
  organization: Florida State University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32667081$$D View this record in MEDLINE/PubMed
BookMark eNpdkcFO3DAQhi0EYlmK1CdAlrj0ku147MT2EXYpICFxoMs18iaTNihxQryhrHrpI_QZeRJclnJAGukf-fs0GnmmbNd3nhj7LGAmAPBr6WYoQesddiBShCSTVu3GHqxIFGZ2wqYh3AOAsQb22URilmkw4oD9Xs5uZ3xOPoyBn40DufH5z18XAsUqeT_Qo2vIF8S7ijv_VNN6E7PkJUUWQv1IPGzaft21gdeeIwi75eNQ-x98_ZPiGwKf39xdLeLoiPvIqa2LT2yvck2go7c8ZMtv59_nl8n1zcXV_PQ66VGmOlFakl5hqh0UlUlBolRpKZV2DmElUBNSKg1RhZasKq1BJYDQoXEFVUYesi_buf3QPYwU1nlbh4KaxnnqxpCjQgU2U1JF9eSDet-Ng4_bRUsZRMyEjNbxmzWuWirzfqhbN2zy_98ahWQr_Kob2rxzAfm_c-Wly1_PlS9OX1O-AFYmhrM
ContentType Journal Article
Copyright 2020 Wiley Periodicals LLC
2020 Wiley Periodicals LLC.
Copyright_xml – notice: 2020 Wiley Periodicals LLC
– notice: 2020 Wiley Periodicals LLC.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
P64
RC3
7X8
DOI 10.1002/da.23077
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Psychology
EISSN 1520-6394
EndPage 956
ExternalDocumentID 32667081
DA23077
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Military Suicide Research Consortium
  funderid: W81XWH‐16‐20003
– fundername: Military Suicide Research Consortium
  grantid: W81XWH-16-20003
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
31~
33P
36B
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AANHP
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABIVO
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACHQT
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFGKR
AFPWT
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H13
HBH
HF~
HHY
HVGLF
HZ~
IX1
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RHX
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
TUS
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WQJ
WRC
WVDHM
WXI
XG1
XPP
XV2
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
RPM
7TK
8FD
FR3
K9.
P64
RC3
7X8
BENPR
ID FETCH-LOGICAL-p2357-473e7b257a0cf85032345d347aa20b127e2e538eef29e94d982410e2a28acef83
IEDL.DBID DR2
ISSN 1091-4269
1520-6394
IngestDate Thu Jul 10 22:17:02 EDT 2025
Fri Jul 25 22:43:41 EDT 2025
Thu Apr 03 07:00:58 EDT 2025
Wed Jan 22 16:32:32 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords COVID-19
anxiety
social isolation
mood disorders
unemployment
economic hardship
depression
pandemic
Language English
License 2020 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p2357-473e7b257a0cf85032345d347aa20b127e2e538eef29e94d982410e2a28acef83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6542-8281
PMID 32667081
PQID 2448222613
PQPubID 946360
PageCount 3
ParticipantIDs proquest_miscellaneous_2424096434
proquest_journals_2448222613
pubmed_primary_32667081
wiley_primary_10_1002_da_23077_DA23077
PublicationCentury 2000
PublicationDate October 2020
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: October 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Depression and anxiety
PublicationTitleAlternate Depress Anxiety
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
References 2013
2020
2018; 86
References_xml – year: 2020
  article-title: Suicide mortality and coronavirus disease 2019—a perfect storm?
  publication-title: JAMA Psychiatry
– volume: 86
  start-page: 946
  issue: 11
  year: 2018
  end-page: 960
  article-title: Anxiety sensitivity and suicidal idea/risk: A meta‐analysis
  publication-title: Journal of Consulting and Clinical Psychology
– year: 2020
  article-title: Mental health and the Covid‐19 pandemic
  publication-title: New England Journal of Medicine
– year: 2013
– year: 2020
SSID ssj0008980
Score 2.6753697
Snippet Background The disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood...
The disruptions to daily life caused by the coronavirus disease 2019 (COVID-19) pandemic may have impacted mental health, particularly mood disorders. This...
BackgroundThe disruptions to daily life caused by the coronavirus disease 2019 (COVID‐19) pandemic may have impacted mental health, particularly mood...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 954
SubjectTerms Adult
Anxiety
Anxiety disorders
Anxiety Disorders - epidemiology
Betacoronavirus
Census
Censuses
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Depression
economic hardship
Emotional disorders
Humans
Mental depression
Mental disorders
Mood
Mood disorders
pandemic
Pandemics
Pneumonia, Viral - epidemiology
Prevalence
SARS-CoV-2
social isolation
unemployment
Title U.S. Census Bureau‐assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID‐19 pandemic
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fda.23077
https://www.ncbi.nlm.nih.gov/pubmed/32667081
https://www.proquest.com/docview/2448222613
https://www.proquest.com/docview/2424096434
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUlp1zaJk3bbT5QIfTmjSPJlnVMdrukgbTQZkOgByNbYwhlvSbeDfm45CfkN-aXZEZab2jpofQk8MhGeDSjZ83TM2O7pTaJALkfFUZCpKxSUWFVFVWpdUI6WVhDp5FPvqZHY3V8npwvWJV0FiboQyw33CgyfL6mALdFu_csGuqsJzHTQXKiahEe-v6sHJWZLAgRGPxEEqnpdGdjsdfd-DdM-TtE9WvM6BX72Y0uUEt-9eezol_e_iHc-H_Df81eLqAnPwhzZY29gHqdrS4z4M0bdjfu_-jzAf39ouWHxFefP94_WF8XBsebS9IGp1TApxW39TXxPbF1vOPTXgFvbybNbDpp-UXNcdk3we4PQ3IEm3hNxHzw7ezLEB-N5oZ2sScX5QYbjz6fDo6ixd8ZooYkciKlJegCI97GZZUlsRRSJU4qba2Ii32hQQBmU4BKGDDKmQzBQgzCisyWUGXyLVuppzW8ZzwBwlkmNrqiOl5phFWppEJbpp2uZI9tdZ7KFyHW5ohLCNwgHOmxj0szBgdVPGwN0zn1QcBCimOqx94FD-dNUPHIEbemGgFRj33yfloagpCzyJ3NvYfy4YFvP_xrx022Su8yUP622Mrscg7bCF1mxY6fpE-b0uf6
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VcmgvlN-yUMBIiFu2qe3EsTiVXaot9Ecq3aqHSpETT6QKbTbq7lYULjwCz8iT4LE3WxVxqHqylHGiJOMZf_aMvwF4VyqdcBRbUaEFRtJIGRVGVlGVGsuFFYXRdBp5_yAdDOXn0-R0CT60Z2ECP8Riw40sw_trMnDakN68Zg21xmcxq3twnwp6U_mC_tE1d1Sms0BFoN0iiae6ZZ6N-WZ75_9Q5U2Q6meZnTU4a98vJJd8686mRbf88Q914x0_4CE8mKNPth2GyyNYwvoxrC6c4NUT-Dnsfu2yHhXAmLCPlLI--_Prt_GhYbSsuSB6cPIGbFwxU3-nlE_XWtam1F4im1yNmul4NGHnNXMzvw5yfx6SObzprvGY9Q5Pdvvu0U7c0Eb26Lx8CsOdT8e9QTQv0BA1xJITSSVQFc7oTVxWWRILLmRihVTG8LjY4go5OoeKWHGNWlqdObwQIzc8MyVWmXgGy_W4xufAEiSopWOtKgrllZobmQqKtWXKqkp0YKNVVT63sknuoAnhG4dIOvB2IXb2QUEPU-N4Rn0cZiHSMdmB9aDivAlEHrmDrqlymKgD772iFoLA5cxza3Kvoby_7dsXt-34BlYGx_t7-d7uwZeXsEr_NWQAbsDy9GKGrxySmRav_Yj9CyKb7BQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1BkVAvlM-yUMBIiFu2qe3E8bHssmr5KAhYVIlD5MS2VKHNRt3disKlP6G_sb-kM_ZmKxAHxMlSxomsjGf84nl-AXhRK51xJ3aSSguXSCNlUhnpE58by4UVldF0Gvn9Qb43lm8Os8Mlq5LOwkR9iNWGG0VGyNcU4K3121eiodYEErO6DjdkjrFCgOjTlXRUoYuoRKDxG4nnuhOeTfl2d-ffQOXvGDUsMqMN-NYNL3JLvvcX86pf__xDufH_xn8bbi2xJ9uNk-UOXHPNXVhfpcDTe_Br3P_cZwP6_cWMvSLC-uLi7NyEwrCzrD0mcXDKBWzqmWl-EOETW8s6Qu2JY7PTSTufTmbsqGG47utoD6chGaJNvMZTNvjwdX-Ij0ZzS9vYk6P6PoxHr78M9pLl7xmSljRyEqmEUxWGvElrX2Sp4EJmVkhlDE-rHa4cd5hOnfNcOy2tLhAtpI4bXpja-UI8gLVm2riHwDJHQEunWnkq5NWaG5kLqrQVyioverDVeapcxtisRGBC6AbxSA-er8wYHVTyMI2bLqgPIhaSHJM92IweLtso41EicM0VIqIevAx-WhmikjMvrSmDh8rhbmgf_WvHZ3Dz43BUvts_ePsY1um1RvrfFqzNjxfuCcKYefU0zNdLhbHqzA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=U.S.+Census+Bureau-assessed+prevalence+of+anxiety+and+depressive+symptoms+in+2019+and+during+the+2020+COVID-19+pandemic&rft.jtitle=Depression+and+anxiety&rft.au=Twenge%2C+Jean+M&rft.au=Joiner%2C+Thomas+E&rft.date=2020-10-01&rft.eissn=1520-6394&rft.volume=37&rft.issue=10&rft.spage=954&rft_id=info:doi/10.1002%2Fda.23077&rft_id=info%3Apmid%2F32667081&rft.externalDocID=32667081
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-4269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-4269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-4269&client=summon